117 related articles for article (PubMed ID: 9301991)
1. PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial.
Stone GG; Shortridge D; Flamm RK; Beyer J; Ghoneim AT; Tanaka SK
J Antimicrob Chemother; 1997 Aug; 40(2):251-6. PubMed ID: 9301991
[TBL] [Abstract][Full Text] [Related]
2. PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin.
Stone GG; Shortridge D; Flamm RK; Beyer J; Stamler D; Tanaka SK
Epidemiol Infect; 1997 Apr; 118(2):119-24. PubMed ID: 9129588
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism.
Shortridge VD; Stone GG; Flamm RK; Beyer J; Versalovic J; Graham DW; Tanaka SK
J Clin Microbiol; 1997 Feb; 35(2):471-3. PubMed ID: 9003618
[TBL] [Abstract][Full Text] [Related]
4. Effect of clarithromycin and omeprazole therapy on the diversity and stability of genotypes of Helicobacter pylori from duodenal ulcer patients.
Owen RJ; Slater ER; Gibson J; Lorenz E; Tompkins DS
Microb Drug Resist; 1999; 5(2):141-6. PubMed ID: 10432275
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.
Chaudhuri S; Chowdhury A; Datta S; Mukhopadhyay AK; Chattopadhya S; Saha DR; Dhali G; Santra A; Nair GB; Bhattacharya S; Berg DE
J Gastroenterol Hepatol; 2003 Feb; 18(2):190-5. PubMed ID: 12542605
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
[TBL] [Abstract][Full Text] [Related]
7. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
[TBL] [Abstract][Full Text] [Related]
8. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
[TBL] [Abstract][Full Text] [Related]
9. PCR and RFLP analysis for identification and typing of Helicobacter pylori strains isolated from gastric biopsy specimens.
Simşek IS; Menevşe S; Sahin FI
Tohoku J Exp Med; 2000 Mar; 190(3):213-22. PubMed ID: 10778805
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis.
Warburton VJ; Everett S; Mapstone NP; Axon AT; Hawkey P; Dixon MF
J Clin Pathol; 1998 Jan; 51(1):55-61. PubMed ID: 9577374
[TBL] [Abstract][Full Text] [Related]
11. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
[TBL] [Abstract][Full Text] [Related]
12. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
[TBL] [Abstract][Full Text] [Related]
14. The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Adamsson I; Edlund C; Seensalu R; Engstrand L
Clin Microbiol Infect; 2000 May; 6(5):265-7. PubMed ID: 11168124
[No Abstract] [Full Text] [Related]
15. Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children.
Yang YJ; Yang JC; Jeng YM; Chang MH; Ni YH
Pediatr Infect Dis J; 2001 Jul; 20(7):662-6. PubMed ID: 11465837
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy.
Scholte GH; van Doorn LJ; Cats A; Bloemena E; Lindeman J; Quint WG; Meuwissen SG; Kuipers EJ
Am J Gastroenterol; 2002 Jul; 97(7):1687-95. PubMed ID: 12135019
[TBL] [Abstract][Full Text] [Related]
17. Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA (+) status and clinical outcome.
Yula E; Nagiyev T; Kaya OA; Inci M; Celik MM; Köksal F
Folia Microbiol (Praha); 2013 Mar; 58(2):141-6. PubMed ID: 22956464
[TBL] [Abstract][Full Text] [Related]
18. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
19. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment failure on the CagA EPIYA motif in
Bustamante-Rengifo JA; Matta AJ; Pazos AJ; Bravo LE
World J Gastroenterol; 2017 Mar; 23(11):1980-1989. PubMed ID: 28373764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
